ENVAFOLIMAB Single-agent Treatment in Patients With Advanced Solid Tumors

NCT04891198 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

126

Enrollment

INDUSTRY

Sponsor class

Conditions

Solid Tumor

Interventions

DRUG: Envafolimab

Sponsor

3D Medicines (Sichuan) Co., Ltd.